Københavns Fondsbørs har besluttet med virkning fra den 9. februar 2007 at optage 4.471.202 stk. nye aktier à 1 kr. til notering i Genmab. Kapitalforhøjelsen er registreret i Erhvervs og Selskabsstyrelsen. Der henvises til det offentliggjorte prospekt.
Recommended Reading
-
Media ReleaseCOPENHAGEN, Denmark; August 25, 2026Genmab A/S (Nasdaq: GMAB) announced today that members of its Executive Committee will participate in fireside chats at the following investor...
Read More -
Company Announcement COPENHAGEN, Denmark; August 11, 2026 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 24,592 shares as a consequence of the exercise of employee warrants. The...
Read More